---
document_datetime: 2023-09-21 17:24:30
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/steps-after-cutoff/prevenar-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf
document_name: prevenar-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf
version: success
processing_time: 3.1101206
conversion_datetime: 2025-12-31 04:52:12.094298
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## STEPS TAKEN AFTER GRANTING THE MARKETING AUTHORISATION

For procedures finalised after 1 September 2004 please refer to module 8B.

| Scope                                                                                                                                                                            | Application number   | Type of modification 1   | Notification/ Opinion issued on 2   | Commission Decision Issued/amended on   |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------|--------------------------|-------------------------------------|-----------------------------------------|
| Quality changes                                                                                                                                                                  | II-0001              | II                       | 26/04/01                            | 06/08/01                                |
| Quality: Change(s) to container Update of Summary of Product Characteristics (SPC) and Package Leaflet (PL)                                                                      | II-0002              | II                       | 26/07/01                            | 29/01/02                                |
| Quality: Change(s) to container Update of SPC and PL                                                                                                                             | II-0003              | II                       | 26/07/01                            | 29/01/02                                |
| Update of the SPC (section 4.8) and PL to incorporate new safety information                                                                                                     | II-0004              | II                       | 23/08/01                            | 28/01/02                                |
| Update of the SPC (section 4.5) to reflect available data on concomitant administration with meningococcal C conjugate vaccine.                                                  | II-0005              | II                       | 20/09/01                            | 19/02/02                                |
| Minor changes in the PL (contact detail of a MAHlocal representative) .                                                                                                          | N-0006               | N                        | 07/11/01                            | 28/02/02                                |
| Change in the specifications of the active substance                                                                                                                             | I-0007               | I                        | 25/06/02                            | 28/06/02                                |
| Update of the SPC (sections 4.8 and 4.9) and PL to incorporate new safety information.                                                                                           | II-0009              | II                       | 19/09/02                            | 6.12.02                                 |
| Extension of the shelf life of the finished product.                                                                                                                             | I-0011               | I                        | 23/09/02                            | 17/10/02                                |
| Extension of the shelf life of the active substance                                                                                                                              | I-0010               | I                        | 26/09/02                            | 08/10/02                                |
| The MAHwishes to update the SPC section 4.4/ 4.5 to include results from two studies assessing co-administration of Prevenar with multicomponent vaccines (hexavalent vaccines). | II-0008 longer       | II                       | 22/05/03                            | 16/09/03                                |
| Change(s) to the test method(s) and/or specifications for the active substance                                                                                                   | II-0012 no           | II                       | 22/05/03                            | 28/05/03                                |
| Change in specification of the medicinal product                                                                                                                                 | I-0013               | I                        | 06/06/03                            | 10/06/03                                |
| Extension of shelf-life as foreseen at time of authorisation                                                                                                                     | I-0016               | I                        | 11/07/03                            | 11/08/03                                |
| Change in test procedure for starting material/intermediate used in manuf. of active substance                                                                                   | I-0014               | I                        | 30/07/03                            | 5/08/03                                 |
| Change in specification of active substance or agent used in manufacturing of active substance - tightening of specification limits product                                      | IB/0025              | IB                       | 18/02/04                            |                                         |
| Change in specification of active substance or agent used in manufacturing of active substance- tightening of specification limits                                               | IB/0024              | IB                       | 18/02/04                            |                                         |
| Change in specification of active substance or agent used in manufacturing of active substance- tightening of specification limits                                               | IB/0022              | IB                       | 18/02/04                            |                                         |
| Change in specification of active substance or agent used in manufacturing of active substance- tightening of specification limits                                               | IB/0021              | IB                       | 18/02/04                            |                                         |
| Change in specification of active substance or agent used in manufacturing of active substance- tightening of specification limits                                               | IB/0020              | IB                       | 18/02/04                            |                                         |
| Addition or replacement of measuring or administration device                                                                                                                    | IA/0030              | IB                       | 15/04/04                            |                                         |
| Change(s) to the test method(s) and/or specifications for the active substance                                                                                                   | II-0019              | II                       | 22/04/04                            | 27/04/04                                |
| Change in the name and/or address of a manufacturer of the finished product                                                                                                      | IA/0035              | IB                       | 24/05/04                            |                                         |
| Change in name and/or address of a manufacturer of the active substance                                                                                                          | IA/0034              | IB                       | 24/05/04                            |                                         |

T refers to a transfer of a Marketing Authorisation in accordance with Commission Regulation (EC) No 2141/96 of 7 November 1996.

1 In accordance with Commission Regulation (EC) No. 542/95 of 10 March 1995, as amended: I refers to a minor variation (Type I variation); II refers to a major variation (Type II variation); I/II refers to a minor variation following the procedure set out in Article 6, 7 and 8 of the Regulation; X refers to an Annex II application. Medicinal product no longer authorised

N refers to a notification in accordance with Article 10(3) of Council Directive 92/27/EEC of 31 March 1992.

2 For Notifications and Type I variations, the date of entry into force of the change is the EMEA Notification date. The Commission Decision will be amended accordingly.

<div style=\"page-break-after: always\"></div>

| Change in test procedure of finished product - minor change to approved test procedure                                                                                                                                                                                                                                         | IA/0040   | IB   | 08/06/04   |          |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------|------|------------|----------|
| Change(s) to the manufacturing process for the active substance                                                                                                                                                                                                                                                                | II-0029   | II   | 23/06/04   | 01/07/04 |
| Change(s) to the test method(s) and/or specifications for the finished product                                                                                                                                                                                                                                                 | II-0026   | II   | 23/06/04   | 01/07/04 |
| The MAHapplied for amendments of sections 4.1, 4.2, 4.4, 4.8 and 5.1 of the SPC to extend the therapeutic indications to the age range from 2 to 5 years. The PL has been amended accordingly. In addition, the list of local representatives of the PL was completed with the contacts of the ten new European Member States. | II-0018   | II   | 23/06/04   | 02/08/04 |
| Change in any part of primary packaging material not in contact with finished product                                                                                                                                                                                                                                          | IA/0045   | IB   | 09/07/04   |          |
| Addition or replacement of measuring or administration device                                                                                                                                                                                                                                                                  | IA/0044   | IB   | 09/07/04   |          |
| Addition or replacement of measuring or administration device                                                                                                                                                                                                                                                                  | IA/0043   | IB   | 09/07/04   |          |
| Change in any part of primary packaging material not in contact with finished product                                                                                                                                                                                                                                          | IA/0049   | IB   | 21/07/04   |          |
| Quality changes                                                                                                                                                                                                                                                                                                                | II/0038   | II   | 29/07/04   | 02/08/04 |
| Change(s) to the manufacturing process for the active substance                                                                                                                                                                                                                                                                | II/0037   | II   | 29/07/04   | 02/08/04 |
| Change(s) to the manufacturing process for the active substance                                                                                                                                                                                                                                                                | II/0033   | II   | 29/07/04   | 02/08/04 |
| Change(s) to the test method(s) and/or specifications for the active substance                                                                                                                                                                                                                                                 | II/0032   | II   | 29/07/04   | 02/08/04 |
| Quality changes                                                                                                                                                                                                                                                                                                                | II/0031   | II   | 29/07/04   | 02/08/04 |
| Change in specification of active substance or agent used in manufacturing of active substance- tightening of specification limits                                                                                                                                                                                             | IB/0046   | IB   | 30/07/04   |          |

## from 2 to 5 years. The PL has been amended accordingly. In addition, the list of local representatives of the PL was completed with the contacts of the ten new European Member States. Change in any part of primary packaging material not in contact with finished product Addition or replacement of measuring or administration device Addition or replacement of measuring or administration device Change in any part of primary packaging material not in contact with finished product Quality changes Change(s) to the manufacturing process for the active substance Change(s) to the manufacturing process for the active substance Change(s) to the test method(s) and/or specifications for the active substance Quality changes Change in specification  of active substance or agent used in manufacturing  of active substance- tightening of specification limits Medicinal product no longer authorised